Back to search

The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas

Data up to Jan 2025

Published1998
Citations102
References26

Total Citations Per Year

Abstract

References (26)

Principles and Practice of Radiation Oncology

1999 • 1,911 citations

Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution.

1986 • 1,371 citations

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

1993 • 872 citations

Glucose utilization of cerebral gliomas measured by [ 18 F] fluorodeoxyglucose and positron emission tomography

1982 • 760 citations

Positron Emission Tomography Using [18F] Fluorodeoxyglucose in Brain Tumors A Powerful Diagnostic and Prognostic Tool

1987 • 446 citations

Cerebral radionecrosis: Incidence and risk in relation to dose, time, fractionation and volume

1981 • 410 citations

Positron emission tomography in patients with glioma a predictor of prognosis

1988 • 378 citations

Principles and Practice of Radiation Oncology

1992 • 356 citations

Head Fixation Device for Reproducible Position Alignment in Transmission CT and Positron Emission Tomography

1981 • 316 citations

An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies.

1994 • 313 citations

Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.

1995 • 290 citations

Intratumoral histologic heterogeneity of gliomas. A quantitative study

1989 • 215 citations

Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas

1995 • 190 citations

Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography

1991 • 174 citations

Regional glucose metabolism and histopathology of gliomas: A study based on positron emission tomography-guided stereotactic biopsy

1996 • 132 citations

The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms

1992 • 130 citations

Long-Term Survival in Patients with Malignant Astrocytoma

1994 • 129 citations

FDG-PET as a Prognostic Indicator in Radiochemotherapy of Glioblastoma

1993 • 98 citations

The use of PET in evaluating patients with primary brain tumours: is it useful?

1995 • 96 citations

Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.

1997 • 84 citations

Patterns of second recurrence of malignant astrocytomas

1990 • 67 citations

Patterns of recurrence of malignant astrocytoma following stereotactic interstitial brachytherapy with iodine-125 implants

1992 • 62 citations

Display of merged multimodality brain images using interleaved pixels with independent color scales.

1994 • 61 citations

Dreidimensionale Bestrahlungsplanung bei Hirntumoren

1998 • 20 citations

Positron emission tomography andin vivo measurements of tumour perfusion and oxygen utilisation

1987 • 12 citations

Histopathology of astrocytomas: Grading, patterns of spread, and correlation with modern imaging modalities

1991 • 10 citations

Cited By (0)

Loading...
The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of… (1998) – International Journal of Radiation Oncology*Biology*Physics | Metascience Observatory Explorer